Keto Diet's Dual Cancer Risk for the Gut
A high-fat ketogenic diet can paradoxically both promote and inhibit tumor growth in different sections of the gut, complicating its potential for cancer prevention or therapy.
New research from MIT has unveiled a nuanced and potentially concerning aspect of the ketogenic diet: while it may reduce colon tumors, it significantly increases small-intestinal tumors in cancer-prone mice. This finding reveals a strikingly different response within neighboring parts of the gut, challenging a singular view of keto's impact on cancer.
The study, published recently in *Cell* (2024), pinpointed the mechanism not to ketones themselves, but to how intestinal stem cells processed the diet’s high levels of fat. This fat-burning activity prompted these cells to multiply more rapidly, raising the potential for cancerous changes. The mice in the study, genetically predisposed to cancer, showed up to a 50% increase in small-intestinal tumors when on a ketogenic diet compared to controls.
The research provides a critical reminder that dietary interventions, even those with perceived health benefits, can have complex and sometimes opposing effects depending on physiological context. Understanding these localized impacts is crucial for anyone considering a ketogenic diet, particularly those with a family history or genetic predisposition to certain cancers.
The take-away is not to dismiss keto entirely, but to approach it with informed caution. For individuals, this means scrutinizing generalized dietary advice and seeking professional guidance, especially when health conditions or predispositions are at play. Understanding the localized effects of diet empowers you to make more precise choices for your long-term health.
The longer view
One headline rarely tells the story. See how today’s news fits the bigger shifts on AI Trends, or learn to read your own data on How it works.